Hostname: page-component-848d4c4894-8bljj Total loading time: 0 Render date: 2024-07-03T17:16:03.713Z Has data issue: false hasContentIssue false
  • English
  • Français

The effect of long chain n-3 fatty acid supplementation on muscle strength in older adults: A systematic review and meta-analysis

Published online by Cambridge University Press:  03 July 2024

M. Timraz ,
A. Binmahfoz ,
T. J Quinn ,
E. Combet  and
S. Gary
M. Timraz
Affiliation:
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK
A. Binmahfoz
Affiliation:
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK
T. J Quinn
Affiliation:
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK
E. Combet
Affiliation:
School of Medicine and Dentistry, University of Glasgow, Glasgow, UK
S. Gary
Affiliation:
School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Muscle strength and mass decline as we age, typically starting around 35–40 years, and can eventually lead to the development of sarcopenia(1). There are currently no effective drug treatments available for either the prevention or treatment of this condition(2) and whilst resistance exercise has efficacy(3) its effectiveness is limited due to issues with uptake and adherence(4). However, emerging research suggests that nutrition may offer a potentially effective approach to delay the age-related decline in muscle mass and function among older individuals(5), with LCn-3 PUFA emerging as a strong candidate.

The main objective of the current study was to perform a systematic literature review with the purpose of exploring the impact of long-chain n-3 polyunsaturated fatty acid (LCn-3 PUFA) relative to control oil supplementation on muscle strength, with secondary outcomes of muscle mass and physical function in older individuals under conditions of habitual physical activity/exercise.

The review protocol was registered with PROSPERO (CRD42021267011) and followed the guidelines outlined in the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statement(6). The search for relevant studies was performed utilizing databases such as PubMed, EMBASE, CINAHL, Scopus, Web of Science, and the Cochrane Central Register of Controlled Trials (CENTRAL) up to June 2023. Randomized controlled trials (RCTs) in older adults comparing the effects of LCn-3 PUFA with a control oil supplement on muscle strength were included.

Five studies(7,8,9,10,11) involving a total of 488 participants (348 females and 140 males) were identified that met the specified inclusion criteria and were included. Upon analyzing the collective data from these studies, it was observed that supplementation with LCn-3 PUFA did not have a significant impact on grip strength (standardized mean difference (SMD) 0.61, 95% confidence interval [−0.05, 1.27]; p = 0.07) in comparison to the control group. However, there was a considerable level of heterogeneity among the studies (I2 = 90%; p < 0.001). As secondary outcomes were only measured in a few studies, with significant heterogeneity in methods, meta-analyses of muscle mass and functional abilities were not performed. Papers with measures of knee extensor muscle mass as an outcome (n = 3) found increases with LCn-3 PUFA supplementation, but studies measuring whole body lean/muscle mass (n = 2) and functional abilities (n = 4) reported mixed results.

With a limited number of studies, our data indicate that LCn-3 PUFA supplementation has no effect on muscle strength or functional abilities in older adults but may increase muscle mass, although, with only a few studies and considerable heterogeneity, further work is needed to confirm these findings.

Type
Abstract
Information
Proceedings of the Nutrition Society , Volume 83 , Issue OCE2: Winter Conference 2023, 5-6 December 2023, Diet and lifestyle strategies for prevention and management of multimorbidity , June 2024 , E215
Check for updates
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Nutrition Society

References

Distefano G & Goodpaster BH (2018) Perspect Med 8, 029785–10.1101.Google Scholar
Won CW (2023) Korean J Fam Med 44, 71–75.Google Scholar
Fiatarone MA, Marks EC, Ryan ND et al. (1990) JAMA 13, 263(22), 3029–34.Google Scholar
Strain T, Fitzsimons C, Kelly P et al. (2016) BMC Public Health 21, 16(1), 1108.Google Scholar
ter Borg S, Luiking YC, van Helvoort A et al. (2018) J Nutr Health Aging 23, 27–34.Google Scholar
Liberati A, Altman DG, Tetzlaff J et al. (2009) PLoS Med 6, 1000100.Google Scholar
The Cochrane Collaboration (2008) [Available at: https://training.cochrane.org/handbook]Google Scholar
Smith GI, Julliand S, Reeds DN et al. (2015) Am J Clin Nutr 102, 115–122.Google Scholar
Logan SL & Spriet LL (2015) PLoS ONE 10, 0144828.CrossRefGoogle Scholar
Hutchins-Wiese HL, Kleppinger A, Annis K et al. (2012) J Nutr Health Aging 1776–80.Google Scholar
Alkhedhairi SA, Alkhayl FFA, Ismail AD et al. (2022) Clin Nutr 41, 1228–1235.Google Scholar